Lloyds Engineering Works: Bela Rajan exits board after second term
- Mrs. Bela Rajan ceased as Independent Director on August 31, 2026
- Exit follows completion of her second consecutive five-year term
- Board expressed gratitude for her contributions and stewardship
- Filing made under Regulation 30 of SEBI Listing Regulations

*this image is generated using AI for illustrative purposes only.
Lloyds Engineering Works announced that Mrs. Bela Rajan ceased to be a Non-Executive Independent Director on August 31, 2026. She completed her second consecutive five-year term with the company.
The Board of Directors and management expressed gratitude for her contributions, guidance, and stewardship during her tenure. The cessation took effect from the closure of business hours on the specified date.
Regulatory Disclosure
The company filed the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure was made in compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Director Details
| Particulars | Details |
|---|---|
| Name | Mrs. Bela Rajan |
| DIN | 00548367 |
| Role | Non-Executive Independent Director |
| Reason for Change | Completion of tenure of second term |
| Date of Cessation | August 31, 2026 |
Rahima Shaikh, Company Secretary and Compliance Officer, signed the filing. The disclosure confirmed that no relationships between directors required reporting for this specific change.
Historical Stock Returns for Lloyds Engineering Works
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.60% | -4.25% | -5.44% | +80.38% | +33.67% | 0.0% |
Has Lloyds Engineering Works initiated a search for a successor to fill the vacant Non-Executive Independent Director seat, and what is the expected timeline for appointment?
How might the departure of Mrs. Bela Rajan impact the company's corporate governance structure or board dynamics during the transition period?
Are there any pending strategic decisions or regulatory approvals that could be influenced by the change in board composition?


































